Published in Blood Weekly, February 20th, 1995
Results from the trials were presented at the 2nd National Conference on Human Retroviruses and Related Infections, held January 29-February 2, 1995, in Washington, D.C. (early results from the European trials were presented in November 1994 at the Second International Congress on Drug Therapy in HIV Infection, held in Glasgow, Scotland). The Phase II trials were not designed to show whether the 3TC/AZT combination...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.